Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $87,513.47 -1.01%
Ethereum $2,974.27 +0.07%
BNB $862.15 -0.20%
Optimism $0.27 +0.06%
Arbitrum $0.19 -2.69%
Solana $124.82 -0.76%
Polygon $0.22 +2.77%
Cosmos $1.93 -1.83%
Avalanche $12.26 -2.27%

Bitcoin $87,513.47 -1.01%
Ethereum $2,974.27 +0.07%
BNB $862.15 -0.20%
Optimism $0.27 +0.06%
Arbitrum $0.19 -2.69%
Solana $124.82 -0.76%
Polygon $0.22 +2.77%
Cosmos $1.93 -1.83%
Avalanche $12.26 -2.27%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B